Skip to search.
New User?
Register
Sign In
Help
Get new Yahoo! Mail apps
Notifications
Help
Mail
My Y!
Yahoo!
Yahoo! Finance
Search
Search Web
Breaking News
Visit Yahoo! News for the latest.
×
Close this window
HOME
INVESTING
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
Education
Commodities
NEWS
Markets
Investing Ideas
Special Editions
Company Finances
RSS Feeds
Video
Photos & Interactives
PERSONAL FINANCE
Career & Education
Insurance
Lifestyle
Loans
Real Estate
Retirement
Saving & Spending
Taxes
Glossary
Your Money 101
MY PORTFOLIOS
Sign in to access My Portfolios
Free trial of Real-Time Quotes
EXCLUSIVES
Breakout
The Daily Ticker
The Exchange
Unexpected Returns
Financially Fit
Just Explain It
Hot Stock Minute
Cost of Living
CNBC
Big Data Download
Off the Cuff
Talking Numbers
Latest Headlines
Search for share prices
Search for share prices
Finance Search
Wed, May 22, 2013, 11:17PM EDT - U.S. Markets closed
Dow
0.52%
Nasdaq
1.11%
More On SRX.AX
Quotes
Summary
Order Book
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Press Releases
Company Events
Message Boards
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Sirtex Medical Limited (SRX.AX)
-
ASX
10.69
0.08(0.74%)
10:54PM EDT
Add to Portfolio
Press Releases
Get Press Releases for:
Saturday, April 13, 2013
Sirtex Completes Patient Recruitment for SIRFLOX Study Evaluating SIR-Spheres® Microspheres as First-Line Treatment for Colorectal Liver Metastases
Business Wire
( (Sat, Apr 13)
Monday, March 4, 2013
Sirtex Medical Inc. Announces Half-Year Dose Sales Report
Business Wire
( (Mon, Mar 4)
Tuesday, February 19, 2013
Sirtex Medical Inc. Hosts Dinner Symposium at the 2013 American Hepato-Pancreato-Biliary Association’s Annual Meeting
Business Wire
( (Tue, Feb 19)
Thursday, February 14, 2013
Sirtex Medical: Interim report – half-year ended 31 December 2012
Business Wire
( (Thu, Feb 14)
Thursday, January 24, 2013
Large U.S. Multi-Center Study Supports the Safety and Efficacy of Sirtex’s SIR-Spheres® microspheres in Treating Colorectal Liver Metastases
Business Wire
( (Thu, Jan 24)
Tuesday, January 15, 2013
Sirtex Medical Inc. Announces Second Quarter Sales Growth
Business Wire
( (Tue, Jan 15)
95993774